Citadel Advisors’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-7,961
| Closed | -$219K | – | 6211 |
|
|
2025
Q1 | $219K | Buy |
+7,961
| New | +$219K | ﹤0.01% | 4805 |
|
|
2024
Q3 | – | Sell |
-12,698
| Closed | -$346K | – | 6090 |
|
|
2024
Q2 | $346K | Buy |
+12,698
| New | +$346K | ﹤0.01% | 4174 |
|
|
2024
Q1 | – | Sell |
-7,963
| Closed | -$212K | – | 6349 |
|
|
2023
Q4 | $212K | Buy |
+7,963
| New | +$212K | ﹤0.01% | 4551 |
|
|
2023
Q3 | – | Sell |
-22,990
| Closed | -$602K | – | 6083 |
|
|
2023
Q2 | $602K | Buy |
22,990
+14,557
| +173% | +$381K | ﹤0.01% | 3471 |
|
|
2023
Q1 | $220K | Buy |
+8,433
| New | +$220K | ﹤0.01% | 4552 |
|
|
2022
Q3 | – | Sell |
-19,181
| Closed | -$507K | – | 6158 |
|
|
2022
Q2 | $507K | Sell |
19,181
-2,287
| -11% | -$60.5K | ﹤0.01% | 4121 |
|
|
2022
Q1 | $571K | Buy |
+21,468
| New | +$571K | ﹤0.01% | 4311 |
|
|
2021
Q4 | – | Sell |
-23,129
| Closed | -$591K | – | 6698 |
|
|
2021
Q3 | $591K | Buy |
+23,129
| New | +$591K | ﹤0.01% | 4346 |
|
|
2020
Q3 | – | Sell |
-32,687
| Closed | -$748K | – | 4862 |
|
|
2020
Q2 | $748K | Buy |
32,687
+16,445
| +101% | +$376K | ﹤0.01% | 3117 |
|
|
2020
Q1 | $324K | Sell |
16,242
-837
| -5% | -$16.7K | ﹤0.01% | 3730 |
|
|
2019
Q4 | $398K | Buy |
17,079
+3,156
| +23% | +$73.5K | ﹤0.01% | 3693 |
|
|
2019
Q3 | $284K | Buy |
+13,923
| New | +$284K | ﹤0.01% | 3879 |
|
|
2018
Q4 | – | Sell |
-10,650
| Closed | -$248K | – | 4647 |
|
|
2018
Q3 | $248K | Buy |
+10,650
| New | +$248K | ﹤0.01% | 3612 |
|